CoChat

Identification of distinctive interferon gene signatures in different types of myositis

Open access
Pinal-Fernandez, Iago, Casal-Dominguez, Maria, Derfoul, Assia, Pak, Katherine, Plotz, Paul, Miller, Frederick W., Milisenda, Jose C., Grau-Junyent, Josep M., Selva-O'Callaghan, Albert, Paik, Julie, Albayda, Jemima, Christopher-Stine, Lisa, Lloyd, Thomas E., Corse, Andrea M., Mammen, Andrew L. · 2019 · Neurology
Cited by 230

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Objective Activation of the type 1 interferon (IFN1) pathway is a prominent feature of dermatomyositis (DM) muscle and may play a role in the pathogenesis of this disease. However, the relevance of the IFN1 pathway in patients with other types of myositis such as the antisynthetase syndrome (AS), immune-mediated necrotizing myopathy (IMNM), and inclusion body myositis (IBM) is largely unknown. Moreover, the activation of the type 2 interferon (IFN2) pathway has not been comprehensively explored in myositis. In this cross-sectional study, our objective was to determine whether IFN1 and IFN2 pathways are differentially activated in different types of myositis by performing RNA sequencing on muscle biopsy samples from 119 patients with DM, IMNM, AS, or IBM and on 20 normal muscle biopsies. Methods The expression of IFN1- and IFN2-inducible genes was compared between the different groups. Results The expression of IFN1-inducible genes was high in DM, moderate in AS, and low in IMNM and IBM. In contrast, the expression of IFN2-inducible genes was high in DM, IBM, and AS but low in IMNM. The expression of IFN-inducible genes correlated with the expression of genes associated with inflammation and muscle regeneration. Of note, ISG15 expression levels alone performed as well as composite scores relying on multiple genes to monitor activation of the IFN1 pathway in myositis muscle biopsies. Conclusions IFN1 and IFN2 pathways are differentially activated in different forms of myositis. This observation may have therapeutic implications because immunosuppressive medications may preferentially target each of these pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000008128

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 230

Metadata

Authors
Pinal-Fernandez, I., Casal-Dominguez, M., Derfoul, A., Pak, K., Plotz, P., Miller, F. W., Milisenda, J. C., Grau-Junyent, J. M., Selva-O'Callaghan, A., Paik, J., Albayda, J., Christopher-Stine, L., Lloyd, T. E., Corse, A. M., & Mammen, A. L.
Venue
Neurology
Published
2019-09-17
Volume
93
Issue
12
Pages
e1193-e1204
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2969640262
Cited by
230
References
1
FWCI
11.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of distinctive interferon gene signatures in different types of myositis. https://app.cochat.ai/papers/10.1212/wnl.0000000000008128
The paper
Pinal-Fernandez, I., Casal-Dominguez, M., Derfoul, A., Pak, K., Plotz, P., Miller, F. W., Milisenda, J. C., Grau-Junyent, J. M., Selva-O'Callaghan, A., Paik, J., Albayda, J., Christopher-Stine, L., Lloyd, T. E., Corse, A. M., & Mammen, A. L. (2019). Identification of distinctive interferon gene signatures in different types of myositis. Neurology. https://doi.org/10.1212/wnl.0000000000008128

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.